| Effect | Decrease |
| Trial Design | Double blind |
| Trial Length | 24 hours |
| Number of Subjects | 14 |
| Sex | Both Genders |
| Age Range | 65+ |
Acute supplementation of 250mg armodafinil to elderly persons with multiple sclerosis is able to improve memory performance on a list learning task yet appears ineffective in improving fatigue, processing speed, and executive functioning.
